German, Austrian competition authorities approve Merck’s acquisition of Acceleron

Merck expects the acquisition to complement and strengthen its cardiovascular portfolio and pipeline. Credit: Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.